diepoxybutane has been researched along with Multiple Endocrine Neoplasia Type 1 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashizume, K; Katai, M; Nishimura, Y; Sakurai, A; Yamashita, K; Yamazaki, M; Yumita, W | 1 |
| Barbara, L; Baserga, M; Bosoni, D; Cometa, G; Del Vecchio, E; Faccioli, P; Paolucci, G; Tomassetti, P | 1 |
| Hashizume, K; Ikeo, Y; Itakura, Y; Katai, M; Sakurai, A | 2 |
1 trial(s) available for diepoxybutane and Multiple Endocrine Neoplasia Type 1
| Article | Year |
|---|---|
Enhanced sensitivity to alkylating agent in lymphocytes from patients with multiple endocrine neoplasia type 1.
Topics: Antineoplastic Agents, Alkylating; Cell Division; Cell Survival; Chromosome Aberrations; Chromosomes; DNA, Neoplasm; Epoxy Compounds; Humans; Lymphocytes; Monocytes; Multiple Endocrine Neoplasia Type 1 | 2000 |
3 other study(ies) available for diepoxybutane and Multiple Endocrine Neoplasia Type 1
| Article | Year |
|---|---|
Multiple endocrine neoplasia type 1 with unusual concomitance of various neoplastic disorders.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Alkylating Agents; Bone Neoplasms; Cell Survival; Cells, Cultured; Chondrosarcoma; Epoxy Compounds; Female; Humans; Hyperparathyroidism; Lipoma; Lymphoma, B-Cell; Magnetic Resonance Imaging; Mesothelioma; Monocytes; Multiple Endocrine Neoplasia Type 1; Proto-Oncogene Proteins; Tomography, X-Ray Computed; Viscera | 2004 |
Chromosomal instability in multiple endocrine neoplasia type 1. Cytogenetic evaluation with DEB test.
Topics: Adult; Aged; Alkylating Agents; Cells, Cultured; Chromosome Aberrations; Epoxy Compounds; Female; Humans; Male; Middle Aged; Multiple Endocrine Neoplasia Type 1 | 1995 |
Premature centromere division in patients with multiple endocrine neoplasia type 1.
Topics: Adult; Aged; Centromere; Epoxy Compounds; Heterozygote; Humans; Lymphocytes; Middle Aged; Multiple Endocrine Neoplasia Type 1; Mutation; Neoplasm Proteins; Proto-Oncogene Proteins; Reference Values | 1999 |